Dividends Calendar Earnings Calendar
SRPT

SRPT | Sarepta Therapeutics Inc

Sarepta Therapeutics Inc
Category: Company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 6.82B
  • Prev closed:
  • Open: 83.16
  • High: 85.78
  • Low: 82.5
  • 52 week low: 65.3
  • 52 week high: 181.83
  • Dividends:No Dividends

Next ER: November 3, 2021  After Market Closes



Top Stories (SRPT)

    About the Company

    Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    October 27, 2021- / -1.83- / 171.36M
    August 4, 2021-1.02 / -1.3164.09M / 167.07M
    May 5, 2021-2.1 / -1.83146.93M / 145.81MBeat!
    March 1, 2021-2.4 / -1.8145.14M / 150.38M
    November 5, 2020-2.5 / -1.71143.92M / 137.76MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jan 18, 2022 65.57 69.92
    69.92
    65.21
    951.71K -7.78%
    Jan 14, 2022 71.10 72.00
    72.04
    68.82
    1.22M -1.78%
    Jan 13, 2022 72.39 73.32
    74.68
    72.24
    890.71K -2.11%
    Jan 12, 2022 73.95 75.69
    76.53
    72.00
    1.55M -3.13%
    Jan 11, 2022 76.34 75.87
    77.84
    73.75
    1.37M 0.25%
    Jan 10, 2022 76.15 84.01
    84.80
    71.28
    4.88M -10.94%
    Jan 7, 2022 85.50 86.96
    92.00
    84.50
    2.66M -1.61%
    Jan 6, 2022 86.90 84.28
    88.07
    82.92
    727.68K 3.34%
    Jan 5, 2022 84.09 88.61
    90.00
    83.73
    946.64K -5.69%
    Jan 4, 2022 89.16 90.00
    90.90
    86.04
    632.20K -1.39%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1980
    • Employees:743

    News

    News for (SRPT)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Douglas S. Ingram
    • CFO :  Sandy Mahatme
    • General Counsel :  Ty Howton
    • Chief Medical Officer :  Gilmore O’Neill (R&D)

    Talk about Sarepta Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 3, 2021 (Same day)

    disca jll ir cog srpt axgn ath sbra insg osur pvac plya 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 83
    HOLD 17
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInInstagram

    Other stocks 

    c asna gs dnow ash cmc mtb hlt arrs afsi lyb ntnx 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet